Clinical Trial Update: Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab

View source ↗

Summary

A Johns Hopkins-led clinical trial update evaluating retinal atrophy and Neurofilament Light Chain levels in people with multiple sclerosis treated with ofatumu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Retinal Degeneration

Drugs mentioned

• Kesimpta (ofatumumab)

Snippet

Sponsor: Johns Hopkins University | Conditions: Multiple Sclerosis, Tomography, Optical Coherence | Status: ENROLLING_BY_INVITATION